The Role of Functional Probiotic Yogurt Consumption in Medical Weight Loss: A GLP-1 Friendly Nutritional Approach to Metabolic Health in UK Adults

Abstract

Graphical Abstract

Background: Obesity is a major and escalating metabolic health challenge in the United Kingdom, strongly associated with increased risk of type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, and cardiovascular disease. Functional probiotic yogurt has emerged as a potential GLP-1–friendly nutritional strategy to support medical weight reduction through gut microbiota modulation and metabolic regulation. Objective: To evaluate the effects of functional probiotic yogurt consumption on anthropometric indices and metabolic biomarkers in overweight and obese UK adults. Methods: A 16-week randomized controlled dietary intervention was conducted among 90 adults (BMI ≥ 25 kg/m²), allocated into three groups (n = 30 each): Control (healthy diet guidance), Group A (diet + 150 g probiotic yogurt/day), and Group B (diet + 200 g probiotic yogurt/day + lifestyle counseling). Anthropometric parameters (weight, BMI, waist circumference, body fat percentage) and metabolic markers (fasting glucose, lipid profile, HOMA-IR) were assessed at baseline and post-intervention. Statistical analysis was performed using one-way ANOVA under a completely randomized design, followed by Tukey’s HSD test. Results: Significant group differences were observed for weight reduction, BMI, waist circumference, and body fat percentage (p < 0.001). The 200 g yogurt + counseling group demonstrated the greatest weight reduction (6.3 ± 2.1 kg), compared to 4.5 ± 1.8 kg in the 150 g group and 1.9 ± 1.4 kg in controls. Significant improvements were also observed in fasting glucose, LDL cholesterol, total cholesterol, triglycerides, and HOMA-IR (p < 0.01). One-way ANOVA revealed a large effect size for weight reduction (η² = 0.29). Multiple regression analysis indicated that yogurt intake independently predicted weight reduction (β = −0.42, p < 0.001), with lifestyle counseling exerting an additional effect (β = −0.31, p = 0.004). Conclusion: Functional probiotic yogurt consumption, particularly when combined with lifestyle counseling, significantly improved anthropometric and metabolic outcomes in overweight and obese UK adults. These findings support the role of GLP-1–friendly probiotic yogurt as a practical adjunct to structured medical weight loss programs.

Conclusion

The present randomized controlled model demonstrates that functional probiotic yogurt supplementation can significantly improve anthropometric parameters and metabolic biomarkers in overweight and obese adults. The observed reductions in body weight, BMI, waist circumference, and body fat percentage were accompanied by meaningful improvements in fasting glucose, lipid profile, and insulin resistance index, indicating enhanced cardiometabolic regulation.

The high-dose yogurt group combined with lifestyle counseling exhibited the most pronounced benefits, highlighting the synergistic role of dietary intervention and behavioral reinforcement in medical weight management. Statistical modeling confirmed that yogurt intake independently predicted weight reduction, with additional contributions from structured counseling.

Mechanistically, the results are consistent with GLP-1–supportive pathways mediated through short-chain fatty acid production, improved gut microbiota composition, and enhanced insulin sensitivity. Although probiotic supplementation should not be considered a standalone therapy, it represents a practical, accessible, and nutritionally safe adjunct within structured dietary programs.

Despite limitations including short intervention duration and absence of microbiome sequencing, the findings provide clinically relevant evidence supporting functional probiotic yogurt as a supportive nutritional strategy in obesity management. Future long-term, strain-specific, and microbiome-integrated studies are warranted to further clarify mechanistic pathways and sustainability of metabolic benefits.